Astrocytes In Dementia With Lewy Bodies is a cell type relevant to neurodegenerative disease research. This page covers its role in brain function, involvement in disease processes, and significance for therapeutic strategies.
This page provides comprehensive information about the cell type. See the content below for detailed information.
Astrocytes in dementia with Lewy bodies (DLB) display unique pathological changes characterized by alpha-synuclein accumulation and distinctive reactive phenotypes. These astrocytes contribute to disease progression through both inflammatory mechanisms and direct involvement in Lewy body formation.
- Astrocytes internalize extracellular α-syn
- Formation of astrocytic inclusions
- Co-localization with Lewy bodies
- Presence of phosphorylated α-syn (Ser129)
- Upregulation of GFAP
- MHC-II expression increase
- Complement protein production
- Cytokine secretion
- GFAP - Reactive astrocyte marker
- C3 - Complement component
- IL-1β - Pro-inflammatory cytokine
- TNF-α - Inflammatory mediator
- CXCL8 - Chemokine (IL-8)
- Glutamate transporters (EAAT1/2)
- Potassium channels (Kir4.1)
- Gap junction communication (Cx43)
- Lactate export (MCT4)
- Similar astrocytic α-syn accumulation
- More widespread cortical involvement
- Greater cholinergic deficit impact
- Less prominent amyloid pathology
- α-Syn rather than tau in astrocytes
- Different inflammatory cytokine profile
- Less severe astrocytic pathology
- Different α-syn aggregation patterns
- Distinct clinical phenotype
- Astrocyte pathology correlates with cognitive decline
- Motor symptom severity linked to astrocyte reactivity
- Rapid eye movement sleep behavior disorder associations
- CSF glial markers (GFAP, YKL-40)
- Peripheral blood inflammatory markers
- Imaging astrocyte activation
- α-Syn clearance - Immunotherapy approaches
- Inflammation modulation - Anti-cytokine therapies
- Metabolic support - Lactate supplementation
- Restoration of function - Channel modulators
The study of Astrocytes In Dementia With Lewy Bodies has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Brück D, et al. (2016). Astrocytes contribute to alpha-synuclein pathology in DLB. Acta Neuropathologica.
- Kim C, et al. (2020). Astrocytes as an α-synuclein source and target. Nature Reviews Neurology.
- Yatham S, et al. (2019). Astrocytes in Lewy body disease. Movement Disorders.